Q2 2026 revenue declined 3% year-over-year to $3.41B, with net income down to $136M and EPS at $0.53. Europe faced operational challenges, while North America and Specialty saw modest growth but lower margins. Liquidity remains strong, and the board is reviewing strategic alternatives.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.